Narrow Results

Eugenol (EU) has been shown to ameliorate experimental colitis due to its anti-oxidant and anti-inflammatory bioactivities. In this study, DSS-induced acute colitis was established and applied to clarify the regulation efficacy of EU on intestinal barrier impairment and macrophage polarization imbalance along with the inflammatory response. Besides, the adjusting effect of EU on macrophages was further investigated in vitro. The results confirmed that EU intervention alleviated DSS-induced colitis through methods such as restraining weight loss and colonic shortening and decreasing DAI scores. Microscopic observation manifested that EU maintained the intestinal barrier integrity in line with the mucus barrier and tight junction protection. Furthermore, EU intervention significantly suppressed the activation of TLR4/MyD88/NF-$\kappa$B signaling pathways and pro-inflammatory cytokines gene expressions, while enhancing the expressions of anti-inflammatory cytokines. Simultaneously, WB and FCM analyses of the CD86 and CD206 showed that EU could regulate the DSS-induced macrophage polarization imbalance. Overall, our data further elucidated the mechanism of EU’s defensive effect on experimental colitis, which is relevant to the protective efficacy of intestinal barriers, inhibition of oxidative stress and excessive inflammatory response, and reprogramming of macrophage polarization. Hence, this study may facilitate a better understanding of the protective action of the EU against UC.

In this study, eugenol-loaded mPEG-PCL nanoparticles were used to improve the anti-bacterial properties of eugenol in an attempt to eliminate the resistant bacteria. The mPEG-PCL copolymer was prepared by ring-opening polymerization of $\epsilon$-caprolactone monomer in the vicinity of a dry mPEG and a tin (II) octoate catalyst. Polymeric nanoparticles were prepared through the nanoprecipitation procedure. The particle size and zeta potential of mPEG-PCL/eugenol were found to be $157.23\pm 3.81$ nm and $-6.95\pm 0.19$ mV, respectively. The polymeric nanoparticle structure was identified by AFM, FT-IR, and DSC techniques. To evaluate and compare the antibacterial efficiency of mPEG-PCL/eugenol with that of free eugenol, a turbidity assay was used in association with gram-positive and gram-negative bacteria. SEM images were taken from the bacteria before and after exposure to the mPEG-PCL/eugenol. The colony-forming unit per milliliter (CFU/mL) method was used to evaluate the performance of mPEG-PCL/eugenol on the growth rate of bacteria in hospital wastewater. The results showed that the mPEG-PCL/eugenol nanoparticles demonstrated an enormous antibacterial effect in connection with wild gram-negative bacteria strains at 40 $\mu$M concentration and 37^∘C. In the original hospital wastewater, mPEG-PCL/eugenol at the concentration of 0.125 $\mu$M at 25^∘C showed the largest decrease in the total microbial count.

The popularity and acceptance of ayurveda drugs are increasing day by day worldwide due to their low cost and no side effects. Due to high demand of herbal raw materials for the manufacturing of different classical as well as phytoformulation there is scope for adulteration of original drugs with chemically or physically resemble raw drugs. Standardization process conforms the identity, quality and purity of herbal drugs, which can be done by different procedures and by using sophisticated techniques. HPTLC method has advantages over other techniques due to its suitability for herbal drugs, low cost, reproducibility and it is easy to operate as well. An HPTLC method has been developed for the quality testing of Avipattikar churna (AVC) and to discriminate any kind of alteration in drugs composition.